No Effect of Antiviral (Valacyclovir) Treatment in Fibromyalgia: A Double Blind, Randomized Study

Journal of Rheumatology

Volumn 31, Issue 4, 2004, Pages 783-784

  Kendall, Sally Aspegren ^a   Schaadt, Malika Lone Chenoufi ^a   Graff, Lykke Bjerglund ^a   Wittrup, Irene ^a   Malmskov, Hanne ^a   Krogsgaard, Kim ^b   Bartels, Else Marie ^a   Bliddal, Henning ^a   Danneskiold Samsøe, Bente ^a,c  

^a Parker Institute   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

Fibromyalgia; Therapy; Valacyclovir; Virology

Indexed keywords

ANTIVIRUS AGENT; LACTOSE; PLACEBO; VALACICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBROMYALGIA; HEADACHE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING;

ACYCLOVIR; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; JOINTS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SICKNESS IMPACT PROFILE; TABLETS; VALINE;

EID: 1842530394     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Neerinckx E, Van Houdenhove B, Lysens R, Vertommen H, Onghena P. Attributions in chronic fatigue syndrome and fibromyalgia syndrome in tertiary care. J Rheumatol 2000;27:1051-5.
3. Wittrup IH, Jensen B, Bliddal H, Danneskiold-Samsoe B, Wiik A. Comparison of viral antibodies in 2 groups of patients with fibromyalgia. J Rheumatol 2000;28:601-3.
4. Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 1992;92:368-74.
5. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C infection. Arch Intern Med 1997;157:2497-500.
6. Laine M, Luukainen R, Jalava J, Ilonen J, Kuusisto P, Toivanen A. Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology 2000;39:295-9.
7. Rea T, Russo J, Katon W, Ashley RL, Buchwald D. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Arch Intern Med 1999;159:865-70.
8. Ambjorn A. Mine erfaringer med herpestabletteme. [My experiences with Zovir herpes tablets]. Ugeskrift for Laeger 1996;158:2867-8.
9. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
10. Russell IJ. The reliability of algometry in the assessment of patients with fibromyalgia syndrome. J Musculoskel Pain 1998;6:139-52.
11. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.
12. Norregaard J, Lykkegard JJ, Mehlsen J, Danneskiold-Samsoe B. Exercise training in treatment of fibromyalgia. J Musculoskel Pain 1997;5:71-9.
13. Burroughs Wellcome Co. Valacyclovir. Investigators' brochure. January 31, 1995. Research Triangle Park, NC: Burroughs Wellcome Co.; 1995.
14. Bliddal H, Moller HJ, Schaadt M, Danneskiold-Samsoe B. Patients with fibromyalgia have normal serum levels of hyaluronic acid. J Rheumatol 2000;27:2658-9.